New hope for teens with severe hair loss in major drug trial
Disease control
Recruiting now
This study is testing an investigational pill called deuruxolitinib to see if it can help regrow hair in teenagers (ages 12-18) who have lost at least half of their scalp hair due to alopecia areata. For the first 24 weeks, participants will be randomly assigned to receive either…
Phase: PHASE3 • Sponsor: Sun Pharmaceutical Industries, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC